Pictures Of Flea Bites On Humans: Comprehensive Veterinary Reference Guide

Quick Q&A

Question: What do flea bites on humans look like, and how can I distinguish them from other insect bites?

Answer: Flea bites on humans typically appear as small, red, raised bumps (papules) often surrounded by a red halo. They are most commonly found on the lower legs, ankles, and feet, frequently appearing in clusters or linear patterns of three or four bites (often called "breakfast, lunch, and dinner" pattern). Unlike mosquito bites which are more random and singular, flea bites are intensely pruritic (itchy) and may develop into small blisters or become crusted from scratching. The key distinguishing feature is the location (below the knee) and the grouping pattern.

Question: Can humans get diseases from flea bites?

Answer: Yes, fleas are vectors for several zoonotic diseases that can affect humans. The most clinically significant include murine typhus (caused by Rickettsia typhi), cat scratch disease (caused by Bartonella henselae), and in rare cases, plague (caused by Yersinia pestis). Additionally, fleas are intermediate hosts for the tapeworm Dipylidium caninum, which can infect humans, particularly children who accidentally ingest fleas. Flea bites can also cause severe allergic reactions (flea allergy dermatitis) and secondary bacterial infections from scratching.

Introduction

Flea infestations represent one of the most common ectoparasitic problems encountered in small animal veterinary practice worldwide. While the primary hosts are typically companion animals (dogs, cats, and occasionally rabbits), humans frequently become accidental hosts when infestations reach significant levels. Understanding the clinical presentation of flea bites on humans is essential for veterinary professionals, pet owners, and healthcare providers alike, as these bites often serve as the sentinel indicator of an underlying household infestation.

This comprehensive veterinary reference guide provides an exhaustive examination of flea bites on humans, incorporating detailed clinical descriptions, diagnostic imaging references, treatment protocols, and prevention strategies. The information presented herein is synthesized from current veterinary medical literature, parasitology textbooks, and clinical guidelines from major veterinary organizations including the American Veterinary Medical Association (AVMA), the Companion Animal Parasite Council (CAPC), and the European Scientific Counsel Companion Animal Parasites (ESCCAP).

The Flea as a Parasite: Biological Overview

Taxonomy and Species of Medical Importance

The order Siphonaptera comprises over 2,500 species of fleas worldwide, but only a handful are of significant medical and veterinary importance. The most clinically relevant species include:

• Ctenocephalides felis (cat flea): The most common flea infesting domestic cats and dogs worldwide. Despite its name, it is the predominant flea species found on both cats and dogs in North America, Europe, and Australia.
• Ctenocephalides canis (dog flea): More common in parts of Europe and Asia, but less prevalent than C. felis in most regions.
• Pulex irritans (human flea): Historically significant but now relatively uncommon in developed countries; found more frequently in areas with poor sanitation.
• Echidnophaga gallinacea (sticktight flea): Primarily affects poultry but can bite humans.
• Tunga penetrans (chigoe flea): Found in tropical and subtropical regions; causes tungiasis, a condition where the female flea burrows into the skin.

According to the Merck Veterinary Manual, Ctenocephalides felis accounts for over 90% of flea infestations on dogs and cats in North America [1]. This species has adapted exceptionally well to domestic environments and readily bites humans when preferred hosts are unavailable.

Life Cycle and Feeding Behaviour

Understanding the flea life cycle is critical for both clinical diagnosis and effective treatment. Fleas undergo complete metamorphosis with four distinct stages:

1. Egg: Adult female fleas lay eggs on the host, but these eggs are not adhesive and fall off into the environment (bedding, carpets, furniture). A single female can produce 40-50 eggs per day, leading to rapid environmental contamination.

2. Larva: Eggs hatch into larvae within 2-14 days, depending on environmental conditions. Larvae are photophobic (avoid light) and burrow deep into carpets, cracks, and organic debris. They feed on organic matter, including adult flea feces (which contains undigested blood).

3. Pupa: Larvae spin silken cocoons and enter the pupal stage. Pupae are highly resistant to environmental extremes and insecticides. They can remain dormant for months, emerging in response to stimuli such as vibration, heat, and carbon dioxide (indicating the presence of a potential host).

4. Adult: Newly emerged adult fleas seek a blood meal within hours of emergence. They prefer to feed on the primary host but will readily bite humans in the absence of preferred hosts or during heavy infestations.

The complete life cycle can be completed in as little as 2-3 weeks under optimal conditions (70-85°F, 70% humidity), but can extend to several months under less favourable conditions.

Feeding Mechanism and Salivary Components

Adult fleas are obligate blood-feeders, requiring a blood meal for reproduction. The flea's mouthparts are adapted for piercing skin and sucking blood. During feeding, the flea injects saliva containing a complex mixture of bioactive compounds, including:

• Anticoagulants (to prevent blood clotting)
• Vasodilators (to increase blood flow)
• Histamine-like compounds
• Proteolytic enzymes
• Immunomodulatory proteins

It is these salivary components that trigger the host's immune response, leading to the characteristic pruritic (itchy) lesions associated with flea bites. The severity of the reaction depends on the individual's immune sensitivity, with some individuals showing minimal response while others develop severe allergic reactions.

Clinical Presentation of Flea Bites on Humans

Macroscopic Appearance

When examining pictures of flea bites on humans, several characteristic features should be noted:

Primary Lesions:

• Papules: Small (1-3 mm), raised, erythematous (red) bumps
• Wheals: Urticarial (hive-like) lesions that may develop in sensitive individuals
• Vesicles: Small fluid-filled blisters that may form in severe reactions
• Pustules: Pus-filled lesions indicative of secondary bacterial infection

Configuration and Distribution:

• Linear clusters: Flea bites often appear in groups of 3-4 bites in a straight line or zigzag pattern, colloquially known as "breakfast, lunch, and dinner"
• Predilection sites: Lower legs (especially ankles and calves), feet, and around the waistband
• Bilateral symmetry: Bites are often distributed symmetrically on both legs

Secondary Changes:

• Excoriations: Linear scratch marks from intense scratching
• Crusting: Serous or hemorrhagic crusts over scratched lesions
• Lichenification: Thickened, leathery skin from chronic scratching
• Hyperpigmentation: Darkening of the skin in areas of repeated bites
• Impetiginization: Secondary bacterial infection, typically with Staphylococcus aureus or Streptococcus pyogenes

Histological Features

On histopathological examination, flea bites show:

• Perivascular lymphocytic infiltrate (in non-allergic individuals)
• Mixed inflammatory infiltrate including eosinophils (in allergic individuals)
• Intraepidermal spongiosis (intercellular edema)
• Subepidermal blister formation in severe cases

Differential Diagnosis

Several conditions can mimic flea bites on humans. A thorough differential diagnosis is essential for accurate diagnosis:

Clinical Grading of Flea Bite Reactions

The severity of flea bite reactions can be classified into three grades:

Grade I (Mild):

• Fewer than 10 papules
• Mild pruritus
• No secondary infection
• Resolves within 3-5 days without treatment

Grade II (Moderate):

• 10-30 papules with surrounding erythema
• Moderate to severe pruritus
• Some excoriation
• May require topical corticosteroids and antihistamines

Grade III (Severe):

• More than 30 lesions, often with vesiculation
• Severe, debilitating pruritus
• Secondary bacterial infection common
• May require systemic corticosteroids and antibiotics

Diagnostic Approach

Clinical History

A comprehensive history is essential when evaluating suspected flea bites. Key questions include:

1. Pet ownership: Do you have dogs, cats, or other furry pets in the household?
2. Recent exposure: Have you visited homes with pets, animal shelters, or areas with stray animals?
3. Other household members: Are other family members experiencing similar symptoms?
4. Timing: When did the bites first appear? Do they correlate with pet acquisition or recent travel?
5. Pet symptoms: Are your pets scratching, biting at their fur, or showing signs of flea allergy dermatitis?
6. Environmental factors: Have you recently moved, purchased used furniture, or had visitors with pets?
7. Previous treatments: Have you treated your pets for fleas? When and with what product?

Physical Examination

A thorough dermatological examination should include:

• Inspection of the entire skin surface, with particular attention to the lower extremities
• Use of a dermatoscope to visualize the characteristic "flea bite" pattern
• Examination of pets for evidence of flea infestation (flea dirt, live fleas, hair loss, dermatitis)
• Assessment for signs of secondary infection (cellulitis, lymphangitis, fever)

Laboratory Confirmation

While the diagnosis of flea bites is primarily clinical, several methods can confirm flea infestation:

Pet Examination:

• Flea combing: Using a fine-toothed flea comb to collect fleas and flea dirt (flea feces)
• Wet paper test: Placing collected debris on a wet paper towel; flea dirt will dissolve into reddish-brown rings (digested blood)
• Visual inspection: Parting the fur to look for live fleas, particularly on the pet's back, tail base, and inner thighs

Environmental Assessment:

• White sock test: Wearing white socks and walking through suspected areas; fleas may jump onto the socks
• Light trap: Placing a bowl of soapy water under a nightlight; fleas are attracted to warmth and light and will drown

Human Testing:

• Skin biopsy is rarely necessary but may be performed to rule out other conditions
• IgE antibodies to flea saliva can be measured but are not routinely indicated

Zoonotic Implications

Disease Transmission

Fleas are vectors for several zoonotic pathogens that can cause significant human disease:

1. Murine Typhus (Endemic Typhus)

• Causative agent: Rickettsia typhi (and R. felis in some regions)
• Vector: Primarily rat fleas (Xenopsylla cheopis), but cat fleas can also transmit
• Clinical presentation: Fever, headache, myalgia, rash (maculopapular, starting on trunk)
• Epidemiology: More common in tropical and subtropical regions; sporadic cases in the United States, particularly in California, Texas, and Hawaii
• Treatment: Doxycycline is the treatment of choice

2. Cat Scratch Disease (Bartonellosis)

• Causative agent: Bartonella henselae
• Vector: Cat fleas transmit the bacteria among cats; humans acquire infection through cat scratches or bites (contaminated with flea feces)
• Clinical presentation: Papule at inoculation site, regional lymphadenopathy, fever, fatigue
• Complications: In immunocompromised individuals, can cause bacillary angiomatosis, peliosis hepatis, endocarditis
• Treatment: Azithromycin for moderate to severe cases; mild cases may resolve spontaneously

3. Plague

• Causative agent: Yersinia pestis
• Vector: Primarily rodent fleas (Xenopsylla cheopis)
• Clinical presentation: Bubonic (painful lymphadenopathy), septicemic, or pneumonic forms
• Epidemiology: Endemic in parts of the southwestern United States, South America, Africa, and Asia
• Treatment: Streptomycin, gentamicin, or doxycycline

4. Dipylidiasis (Tapeworm Infection)

• Causative agent: Dipylidium caninum
• Transmission: Accidental ingestion of fleas containing cysticercoids (larval stage)
• Clinical presentation: Often asymptomatic; may cause abdominal discomfort, anal pruritus
• Risk factors: Children are at highest risk due to hand-to-mouth behaviour
• Treatment: Praziquantel

5. Tungiasis

• Causative agent: Tunga penetrans (chigoe flea)
• Clinical presentation: Painful, pruritic lesion on feet, often under toenails; female flea burrows into skin
• Epidemiology: Tropical and subtropical regions, particularly sub-Saharan Africa, South America, Caribbean
• Treatment: Surgical removal of the flea

Flea Allergy Dermatitis in Humans

Flea allergy dermatitis (FAD) is a hypersensitivity reaction to flea salivary antigens. While more commonly described in veterinary patients, humans can also develop FAD. The condition is characterized by:

• Immediate hypersensitivity (Type I): Wheal-and-flare reaction within 15-20 minutes of a bite
• Delayed hypersensitivity (Type IV): Papular reaction peaking at 24-48 hours
• Chronic exposure: May lead to persistent papular urticaria, particularly in children

In sensitized individuals, even a single flea bite can trigger a severe reaction that may persist for weeks. The condition can significantly impact quality of life due to intense pruritus and sleep disturbance.

Treatment Protocols

Symptomatic Treatment for Humans

General Measures:

• Wash affected areas with mild soap and cool water
• Apply cold compresses to reduce inflammation and pruritus
• Avoid scratching to prevent secondary infection
• Keep nails short and clean

Topical Therapies:

• Calamine lotion: Provides symptomatic relief through cooling and mild astringent effects
• Topical corticosteroids: Hydrocortisone 0.5-1% cream for mild reactions; stronger preparations (triamcinolone 0.1%) for moderate reactions
• Topical antihistamines: Doxepin cream 5% for pruritus relief
• Local anesthetics: Pramoxine or lidocaine preparations for pain relief
• Antiseptics: Chlorhexidine or povidone-iodine for broken skin

Systemic Therapies:

• Oral antihistamines:
  • First-generation: Diphenhydramine (Benadryl) 25-50 mg every 6-8 hours
  • Second-generation: Cetirizine (Zyrtec) 10 mg daily, loratadine (Claritin) 10 mg daily
• Oral corticosteroids: Prednisone 20-40 mg daily for 3-5 days for severe reactions
• Analgesics: Acetaminophen or ibuprofen for pain associated with extensive bites

Treatment of Secondary Infection:

• Topical antibiotics: Mupirocin 2% ointment for localized impetiginization
• Systemic antibiotics: Cephalexin 500 mg four times daily or clindamycin 300 mg three times daily for cellulitis

Environmental Control

Effective flea control requires a comprehensive approach targeting both the host and the environment. According to the CAPC guidelines, integrated flea management includes [2]:

1. Treat All Pets in the Household:

• Use veterinary-approved flea control products (topical or oral)
• Treat all pets simultaneously, including those that appear flea-free
• Continue treatment year-round in endemic areas

2. Environmental Treatment:

• Vacuuming: Thorough vacuuming of carpets, upholstery, and pet bedding removes up to 50% of flea eggs and 30% of larvae
• Steam cleaning: High-temperature steam cleaning kills all life stages
• Insect growth regulators (IGRs): Methoprene or pyriproxyfen prevent egg and larval development
• Adulticides: Permethrin-based sprays (caution with cats), pyrethrins, or boric acid powders

3. Professional Pest Control:

• Consider professional extermination for severe infestations
• May require multiple treatments at 2-4 week intervals

4. Outdoor Management:

• Treat shaded areas where pets rest
• Keep grass short
• Remove organic debris
• Consider nematode applications (biological control)

Veterinary Treatment for Pets

The veterinary approach to flea control has evolved significantly with the development of safe, effective systemic products. According to the AAHA/AVMA guidelines, modern flea control should include [3]:

Adulticides (Kill Adult Fleas):

• Isoxazolines: Afoxolaner (NexGard), fluralaner (Bravecto), sarolaner (Simparica), lotilaner (Credelio)
  • Highly effective, rapid kill
  • Oral administration
  • Monthly or quarterly dosing
• Nitenpyram (Capstar): Rapid kill (within 30 minutes), short duration (24 hours)
• Imidacloprid (Advantage): Topical, monthly application
• Fipronil (Frontline): Topical, monthly application

Insect Growth Regulators (IGRs):

• Lufenuron (Program): Oral, monthly; inhibits chitin synthesis in eggs
• Methoprene/Pyriproxyfen: Often combined with adulticides in topical products

Integrated Products:

• Selamectin (Revolution): Topical, also treats heartworm and ear mites
• Spinosad (Comfortis): Oral, monthly
• Fluralaner (Bravecto): Oral or topical, 3-month duration

Prevention Strategies

Personal Protection

• Avoid areas with known flea infestations
• Wear long pants and socks when walking in wooded or grassy areas
• Use EPA-registered insect repellents containing DEET, picaridin, or oil of lemon eucalyptus
• Treat clothing with permethrin (for outdoor activities)

Household Prevention

• Regular vacuuming (at least weekly)
• Wash pet bedding in hot water weekly
• Maintain clean indoor environment
• Inspect second-hand furniture before bringing indoors
• Use door mats and shoe removal protocols

Pet Prevention

• Year-round flea prevention (as recommended by AVMA and CAPC)
• Regular grooming and inspection
• Avoid contact with stray animals
• Maintain flea control even in winter months (fleas survive indoors)

Special Populations

Children

Children are particularly susceptible to flea bites and their complications:

• Increased exposure: Children often play on floors and carpets where fleas are present
• Severe reactions: Children may develop papular urticaria, a persistent hypersensitivity reaction
• Risk of infection: Secondary bacterial infections are more common due to scratching
• Dipylidiasis risk: Children may accidentally ingest fleas, leading to tapeworm infection

Management considerations:

• Use age-appropriate antihistamines
• Avoid topical corticosteroids on large body surface areas
• Educate children about not scratching
• Keep fingernails short and clean

Immunocompromised Individuals

Patients with compromised immune systems face higher risks from flea-borne diseases:

• HIV/AIDS: Increased risk of severe bartonellosis, including bacillary angiomatosis
• Organ transplant recipients: Higher risk of disseminated infection
• Chemotherapy patients: Increased susceptibility to secondary bacterial infections
• Elderly: Reduced immune response, higher risk of complications

Management considerations:

• More aggressive flea control in the environment
• Prompt medical evaluation for any signs of systemic infection
• Consider prophylactic antibiotics in high-risk situations

Pregnant Women

While flea bites themselves do not pose direct risks to pregnancy, the associated diseases can:

• Murine typhus: Can cause pregnancy complications if untreated
• Cat scratch disease: Rarely associated with fetal infection
• Treatment considerations: Avoid tetracyclines (doxycycline) in pregnancy; use erythromycin or azithromycin

Regional Considerations

North America

• Predominant species: Ctenocephalides felis (cat flea)
• Endemic diseases: Murine typhus (California, Texas, Hawaii), plague (Southwestern US)
• Seasonal patterns: Peak flea activity in late summer and early fall; year-round in warmer climates
• Guidelines: CAPC recommends year-round flea prevention for all pets

Europe

• Predominant species: C. felis in most regions; C. canis more common in parts of Eastern Europe
• Endemic diseases: Dipylidiasis common; murine typhus sporadic
• Seasonal patterns: Seasonal in Northern Europe; year-round in Mediterranean regions
• Guidelines: ESCCAP recommends flea control based on risk assessment

Australia

• Predominant species: C. felis is the primary flea species
• Endemic diseases: Murine typhus (particularly in Western Australia); flea-borne spotted fever (Rickettsia felis)
• Seasonal patterns: Year-round in northern Australia; seasonal in southern regions
• Guidelines: Australian Veterinary Association recommends year-round flea prevention

Canada

• Predominant species: C. felis (cat flea)
• Endemic diseases: Less common due to colder climate; Dipylidiasis most common
• Seasonal patterns: Strongly seasonal (May to October) in most provinces; year-round in British Columbia
• Guidelines: CVMA recommends seasonal flea prevention with year-round consideration for indoor pets

Complications and When to Seek Medical Attention

Indications for Medical Evaluation

• Signs of secondary infection (increasing redness, warmth, swelling, purulent drainage)
• Fever, chills, or lymphadenopathy
• Extensive or severe reactions
• Persistent symptoms despite over-the-counter treatments
• Signs of allergic reaction (urticaria beyond bite sites, angioedema, difficulty breathing)
• Bites involving the face, eyes, or genitalia
• Immunocompromised patients with any flea bites

Potential Complications

• Impetigo: Superficial bacterial infection, common in children
• Cellulitis: Deeper bacterial infection requiring systemic antibiotics
• Lymphangitis: Inflammation of lymphatic vessels, indicating spread of infection
• Post-inflammatory hyperpigmentation: Dark spots that may persist for months
• Scarring: From deep excoriation or secondary infection
• Psychological impact: Anxiety, sleep disturbance, social embarrassment

Prognosis

The prognosis for uncomplicated flea bites is excellent. Most lesions resolve within 1-2 weeks with appropriate symptomatic treatment. However, in sensitized individuals, lesions may persist for 3-4 weeks even after the source of infestation has been eliminated.

The key to successful management lies in breaking the flea life cycle through comprehensive treatment of pets and the environment. Without environmental control, reinfestation is inevitable, and human symptoms will persist.

Frequently Asked Questions

Can fleas live on humans?

Fleas do not typically live on humans as they prefer furry hosts. However, they will readily bite humans for a blood meal. Adult fleas may temporarily reside on human clothing or in human hair but cannot complete their life cycle on human hosts.

How long do flea bites last on humans?

In non-sensitized individuals, flea bites typically resolve within 3-7 days. In individuals with flea allergy dermatitis, lesions may persist for 2-4 weeks. Scratching can prolong healing and increase the risk of secondary infection.

Can flea bites cause hair loss in humans?

Flea bites themselves do not cause hair loss. However, severe scratching of the scalp (in cases where fleas have infested the hair) can lead to traumatic alopecia (hair loss from pulling or scratching).

Do flea bites itch more at night?

Flea bites can itch more at night due to several factors: increased blood flow to the skin (circadian rhythm), reduced distraction, and the fact that fleas are more active in the evening hours.

Can you get fleas from your pet sleeping in your bed?

Yes. If your pet has fleas, they can easily transfer to your bedding. Flea eggs and flea dirt (feces) can accumulate in bedding, providing an ideal environment for flea development. This is why washing pet bedding in hot water is a critical component of flea control.

How do I know if my pet has fleas?

Common signs include excessive scratching, biting at the tail base, hair loss (especially on the lower back), and the presence of small black specks (flea dirt) on the skin. Parting the fur may reveal live fleas moving quickly through the coat. A flea comb can help confirm the diagnosis.

Are there natural remedies for flea bites?

While several natural remedies are suggested (aloe vera, tea tree oil, apple cider vinegar), their efficacy is not well-established. Tea tree oil should be used with caution as it can cause allergic reactions in some individuals. The most reliable treatments remain topical corticosteroids and oral antihistamines.

Can indoor-only pets get fleas?

Yes. Fleas can enter homes on clothing, shoes, or through open doors and windows. They can also be brought in by visitors with pets or through infested second-hand furniture. Indoor-only pets require year-round flea prevention, particularly in multi-pet households.

Conclusion

Flea bites on humans represent a common and clinically important manifestation of household flea infestations. Understanding the characteristic appearance, distribution, and clinical progression of flea bites is essential for accurate diagnosis and effective management. The images and descriptions provided in this guide serve as a reference for veterinary professionals and pet owners alike.

The cornerstone of flea bite management lies not in treating the bites themselves, but in eliminating the underlying infestation. This requires an integrated approach combining veterinary-approved flea control products for all pets, thorough environmental treatment, and, in severe cases, professional pest control services.

Veterinary professionals play a crucial role in educating pet owners about the zoonotic potential of flea infestations and the importance of year-round prevention. By implementing comprehensive flea control programs, we can protect both animal and human health, improving the quality of life for all members of the household.

References

1. Merck Veterinary Manual. Flea Infestation in Dogs and Cats. Merck Sharp & Dohme Corp., 2023.

2. Companion Animal Parasite Council (CAPC). Flea Guidelines. CAPC, 2023.

3. American Animal Hospital Association (AAHA). AAHA Canine and Feline Parasite Control Guidelines. AAHA, 2022.

4. European Scientific Counsel Companion Animal Parasites (ESCCAP). ESCCAP Guideline 3: Control of Ectoparasites in Dogs and Cats. ESCCAP, 2022.

5. American Veterinary Medical Association (AVMA). Flea and Tick Control. AVMA, 2023.

6. Canadian Veterinary Medical Association (CVMA). Flea Control in Pets. CVMA, 2022.

7. Australian Veterinary Association (AVA). Flea Control Guidelines. AVA, 2023.

8. Federation of Veterinarians of Europe (FVE). Position Paper on Parasite Control. FVE, 2022.

9. Cornell Feline Health Center. Fleas and Your Cat. Cornell University College of Veterinary Medicine, 2023.

10. VCA Animal Hospitals. Flea Infestation in Dogs and Cats. VCA, 2023.

11. DVM360. Flea Allergy Dermatitis: Diagnosis and Management. DVM360, 2022.

12. Centers for Disease Control and Prevention (CDC). Fleas and Disease. CDC, 2023.

13. World Health Organization (WHO). Vector-borne Diseases: Fleas. WHO, 2022.

14. Blagburn BL, Dryden MW. Biology, treatment, and control of flea and tick infestations. Vet Clin North Am Small Anim Pract. 2009;39(6):1173-1200.

15. Rust MK. The biology and ecology of cat fleas and advancements in their management. Med Vet Entomol. 2017;31(1):1-12.

16. Dryden MW, Rust MK. The cat flea: biology, ecology and control. Vet Parasitol. 1994;52(1-2):1-19.

17. Bitam I, Dittmar K, Parola P, et al. Fleas and flea-borne diseases. Int J Infect Dis. 2010;14(8):e667-e676.

18. Dobler G, Pfeffer M. Fleas as parasites of the family Canidae. Parasit Vectors. 2011;4:139.

19. Halos L, Beugnet F, Cardoso L, et al. Flea control failure? Myths and realities. Trends Parasitol. 2014;30(5):228-233.

20. Marchiondo AA, Holdsworth PA, Fourie LJ, et al. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestation on dogs and cats. Vet Parasitol. 2013;194(1):84-97.